Slow receptor dissociation is not a key factor in the duration of action of inhaled long-acting β2-adrenoceptor agonists
about
New combination treatments in the management of asthma: focus on fluticasone/vilanterolCOPD: maximization of bronchodilation.Pharmacotherapy of critical asthma syndrome: current and emerging therapies.Update on ultra-long-acting β agonists in chronic obstructive pulmonary disease.The acute management of asthma.On the 'micro'-pharmacodynamic and pharmacokinetic mechanisms that contribute to long-lasting drug action.Long Receptor Residence Time of C26 Contributes to Super Agonist Activity at the Human β2 Adrenoceptor.Cell membranes… and how long drugs may exert beneficial pharmacological activity in vivoKv 11.1 (hERG)-induced cardiotoxicity: a molecular insight from a binding kinetics study of prototypical Kv 11.1 (hERG) inhibitors.Non-equivalence of Key Positively Charged Residues of the Free Fatty Acid 2 Receptor in the Recognition and Function of Agonist Versus Antagonist Ligands.Binding kinetics differentiates functional antagonism of orexin-2 receptor ligands.Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalizationG Protein-Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands.Micro-pharmacokinetics: Quantifying local drug concentration at live cell membranes.Characterization of Kinetic Binding Properties of Unlabeled Ligands via a Preincubation Endpoint Binding Approach.Detection and pharmacokinetics of salmeterol in thoroughbred horses following inhaled administration.
P2860
Q26852898-ED94B9CC-DD55-4641-8783-94C22E7514E4Q34436393-B23CF8DD-F738-4FB7-8079-C719B4AEF4CFQ38157770-4E4262F2-3975-4E0C-9E90-88B3E3F9F217Q38241442-909ED390-1A88-4038-891C-FC4AB592004AQ38248502-4E5912B3-D40E-49FF-934E-3F0C74962D32Q38545579-9087B497-D017-48DF-AC31-33DE1F4E33A8Q38803217-24D16CD3-F682-4682-A2F5-678C52925696Q38822818-C2CEDD12-C246-46B2-86D4-4D3341139996Q39116722-2CDB35AB-E27C-4F23-AE4B-ABB5F34C0220Q41449385-F79251AE-0BD6-4A2A-B3C0-84658BC03FBEQ41895360-07A8857D-CDE6-467C-BBA0-6E01CA5C40AFQ42249769-AAFAE6EF-C8EA-4A0F-87CA-DEA6E1BC7D7FQ46308914-894844FB-CFFA-4293-B0EE-1C537227B900Q50330984-7BCFA244-307C-4981-AEAC-6D31176D51B6Q50632046-7742082E-2843-4B0D-9012-60728198AAB9Q50948358-DFAE4078-AE87-4FFF-8A13-404B3190EA75
P2860
Slow receptor dissociation is not a key factor in the duration of action of inhaled long-acting β2-adrenoceptor agonists
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Slow receptor dissociation is ...... cting β2-adrenoceptor agonists
@en
Slow receptor dissociation is ...... cting β2-adrenoceptor agonists
@nl
type
label
Slow receptor dissociation is ...... cting β2-adrenoceptor agonists
@en
Slow receptor dissociation is ...... cting β2-adrenoceptor agonists
@nl
prefLabel
Slow receptor dissociation is ...... cting β2-adrenoceptor agonists
@en
Slow receptor dissociation is ...... cting β2-adrenoceptor agonists
@nl
P2860
P1476
Slow receptor dissociation is ...... cting β2-adrenoceptor agonists
@en
P2093
David A Sykes
Steven J Charlton
P2860
P304
P356
10.1111/J.1476-5381.2011.01639.X
P407
P577
2012-04-01T00:00:00Z